These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6279968)

  • 21. Purification of activins from androgen-independent Shionogi carcinoma cells demonstrates enhanced expression of activin betaB-subunit under androgen-depleted cell conditions in vitro and in vivo.
    Tanaka A; Hasegawa Y; Hakamata Y; Kamiakito T; Kuriki K; Yoshida H; Fukayama M
    J Cell Physiol; 2001 Aug; 188(2):194-200. PubMed ID: 11424086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific triiodothyronine binding by tumor cells and spleen cells in a thyroid hormone dependent mouse tumor system.
    Gupta MK; Chiang T; Deodhar SD
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):819-23. PubMed ID: 6277641
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Shafie SM; Hilf R
    Cancer Res; 1981 Mar; 41(3):826-9. PubMed ID: 6780189
    [No Abstract]   [Full Text] [Related]  

  • 24. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine mediation of psychosocial stressor effects on mouse mammary tumor growth.
    Rowse GJ; Weinberg J; Bellward GD; Emerman JT
    Cancer Lett; 1992 Jul; 65(1):85-93. PubMed ID: 1511412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Animal experimental models of breast cancer for therapeutic testing of hormones and antihormones].
    Naundorf H
    Arch Geschwulstforsch; 1988; 58(5):345-56. PubMed ID: 3060043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115.
    Seike H; Takeuchi M; Kitamura Y; Sato B; Yamaguchi K; Matsumoto K
    Anticancer Res; 1983; 3(1):35-9. PubMed ID: 6830149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model.
    Miyake H; Tolcher A; Gleave ME
    Cancer Res; 1999 Aug; 59(16):4030-4. PubMed ID: 10463603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
    Cho-chung YS; Doud FJ
    Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor characteristics of the rat mammary carcinoma cell line 64-24.
    Eil C; Douglass EC; Rosenburg SM; Kano-Sueoka T
    Cancer Res; 1981 Jan; 41(1):42-8. PubMed ID: 6256064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of prostaglandin F2 alpha on the growth of a hormone-dependent rat mammary tumor.
    Jubiz W; Frailey J; Smith JB
    Cancer Res; 1979 Mar; 39(3):998-1000. PubMed ID: 427787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine and estrogen metabolism--possible implications of smoking for growth and outcome of treatment of hormone-dependent cancer? Discussion of experimental results.
    Zeller WJ; Berger MR
    J Cancer Res Clin Oncol; 1989; 115(6):601-3. PubMed ID: 2606936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action mechanisms of physiological doses of androgen or pharmacological doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice.
    Nakamura N; Nishizawa Y; Noguchi S; Uchida N; Sato B; Matsumoto K
    J Steroid Biochem; 1987; 27(1-3):459-64. PubMed ID: 2961936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgens and breast cancer.
    Labrie F; Simard J; de Launoit Y; Poulin R; Thériault C; Dumont M; Dauvois S; Martel C; Li SM
    Cancer Detect Prev; 1992; 16(1):31-8. PubMed ID: 1551135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of loss of androgen dependency in androgen-dependent tumor].
    Sato N; Suzuki H; Shimazaki J
    Hum Cell; 1993 Sep; 6(3):170-5. PubMed ID: 8297812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of social housing condition on the response of the Shionogi mouse mammary carcinoma (SC115) to chemotherapy.
    Kerr LR; Grimm MS; Silva WA; Weinberg J; Emerman JT
    Cancer Res; 1997 Mar; 57(6):1124-8. PubMed ID: 9067282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy.
    Hansen-Algenstaedt N; Stoll BR; Padera TP; Dolmans DE; Hicklin DJ; Fukumura D; Jain RK
    Cancer Res; 2000 Aug; 60(16):4556-60. PubMed ID: 10969807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.